CTI BioPharma (CTIC) Announces NCCN Guidelines Recommend VONJO for Treatment of Myeloproliferative Neoplasms Apr 14, 2022 07:01AM
NCCN Guidelines® Recommend VONJO™ (pacritinib) for the Treatment of Myeloproliferative Neoplasms Apr 14, 2022 07:00AM
CTI BioPharma (CTIC) Announces Positive Pacritinib Phase 1 Study Results Published in Journal of the American Association for Cancer Research Mar 22, 2021 10:03AM
Phase 1 Trial Demonstrates Encouraging Clinical Benefit and Promising Safety Profile of Pacritinib for the Prevention of Graft-Versus-Host Disease Published in Clinical Cancer Research Mar 22, 2021 10:01AM
CTI BioPharma (CTIC) Phase III Trial Evaluating PFS of PIXUVRI Combined with Rituximab in Patients with Aggressive B-cell NHL Did Not Meet Primary Endpoint Jul 9, 2018 07:02AM


Jul 9, 2018 07:00AM Results of Phase III (PIX306) Trial Evaluating Progression-Free Survival of PIXUVRI® (pixantrone) Combined with Rituximab in Patients with Aggressive B-cell Non-Hodgkin Lymphoma
Feb 10, 2016 12:48PM IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces An Ongoing Investigation of Claims against CTI BioPharma Corp. And Strongly Encourages Investors To Contact The Firm
Feb 8, 2016 04:27PM IMPORTANT SHAREHOLDER NOTICE: Goldberg Law PC Announces an Investigation of Claims against CTI BioPharma Corp. and Strongly Encourages Investors to Contact the Firm
Feb 8, 2016 09:30AM Pre-Open Stock Movers 02/08: (APOL) (KGC) (SFM) Higher; (BCRX) (CTIC) (CHK) Lower (more...)
Oct 1, 2015 01:30AM CTI BioPharma And Fred Hutchinson Cancer Research Center Announce International Research Fellowship To Support Innovative Blood-Related Cancer Research
Mar 5, 2015 09:55AM CTI BioPharma (CTIC) Gains on Overseas Chatter
Jan 13, 2014 09:44AM Pre-Open Stock Movers 1/13: (ALNY) (BEAM) (CHC) Higher; (ICPT) (SODA) (LULU) Lower (more...)
Sep 13, 2013 12:36PM Unusual 11 Mid-Day Movers 09/13: (LAKE) (RMTI) (ULTA) Higher; (AVNR) (CRDS) (GALE) Lower